Corvus Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$13.15

-0.60 (-4.36%)

As of Mar 24, 10:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +245.2% upside

Low Target $29.32

Average Target $45.40

High Target $54.46

Current Price $13.15

Current
$13.15

Target
$45.40

$29.32 $45.40 avg $54.46

Scenario Analysis

Bear Case

$29.32

123.0%

Low target

Base Case

$45.40

+245.2%

Avg target

Bull Case

$54.46

+314.1%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$26.95

-51.2% from high

52-Week Low

$2.54

+417.7% from low

Target vs 52W High

$45.40

+68.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%